Hiperlipemia familiar combinada. Criterios diagnósticos y terapéuticos

The treatment of FCH should control dyslipidemia and its associated risk factors such as hypertension and diabetes. The treatment of dyslipidemia is based on a diet low in saturated fat and achieving normal body weight. When these measures fail, pharmacological indications should be based on low-density lipoprotein (LDL)- cholesterol concentrations and do not differ from those in the general population. The pharmacological treatments of choice are statins and fenofibrate or gemfibrozil when triglyceride levels exceed 500 mg/dl.